Advancements in Clinical Trial Methodologies: A Century in Review
DOI:
https://doi.org/10.54878/g50ysx32Keywords:
Randomized Controlled Trials (RCTs), Adaptive Design, Bayesian Design , Platform Trials , Virtual Trials, Precision MedicineAbstract
The evolution of clinical trial design methods over the past century has been profound, driven by the increasing complexity of medical research and technological advancements. Clinical trials have transitioned from simple, static designs to complex, adaptive methodologies, tailored to meet the demands of modern medicine. This review traces the historical development of core methodologies such as randomized controlled trials (RCTs), explores modern innovations like adaptive, Bayesian, and platform designs, and discusses their strengths and limitations. It concludes with an analysis of current challenges and emerging trends, including the integration of artificial intelligence, big data, and personalized medicine, offering insights into the future of clinical trial methodology. Recent advancements highlight the role of decentralized and virtual trials, leveraging digital tools and data integration to streamline trial processes and improve accessibility. These innovations reflect a dynamic and rapidly evolving field, poised to transform healthcare and medical research in unprecedented ways.
References
Fisher, R. A. (1935). The design of experiments. London: Oliver and Boyd.
Hill, A. B. (1948). Streptomycin treatment of pulmonary tuberculosis. BMJ, 2(4582), 769-782. https://doi.org/10.1136/bmj.2.4582.769
Adaptive designs in clinical trials. (2020). The Lancet. Retrieved from https://www.thelancet.com
Bayesian clinical trials. (2018). New England Journal of Medicine. https://doi.org/10.1056/nejmct1812036
The RECOVERY Collaborative Group. (2020). Dexamethasone in hospitalized patients with Covid-19. New England Journal of Medicine, 384, 693-704. https://doi.org/10.1056/nejmoa2021436
REMAP-CAP Investigators. (2021). Effectiveness of treatments for community-acquired pneumonia: An adaptive platform trial. JAMA, 326(10), 912-921. https://doi.org/10.1001/jama.2021.13977
AGILE Consortium. (2022). Bayesian adaptive platform trial for SARS-CoV-2 therapies: Early phase results. The Lancet, 399, 1234-1241. https://doi.org/10.1016/s0140-6736(22)00345-x
Meyer, E. L., & Finn, R. S. (2020). The evolution of master protocol clinical trial designs: A systematic review. Clinical Therapeutics, 42(7), 1330-1340. https://doi.org/10.1016/j.clinthera.2020.05.017
Wang, S. (2021). Evolution of global clinical trials with adaptive design. Clinical Research and Trials, 7(1), 2-5. https://doi.org/10.15761/crt.1000335
EFPIA. (2020). Innovation in clinical trial design: A review of the clinical trial design landscape. European Federation of Pharmaceutical Industries and Associations. Retrieved from https://www.efpia.eu
FDA. (2023). Decentralized clinical trials for drugs, biologics, and devices: Guidance for industry. U.S. Food and Drug Administration. Retrieved from https://www.fda.gov
Real-world evidence in clinical trials: Challenges and opportunities. (2023). Digital Health Journal. Retrieved from https://www.digitalhealthjournal.com
BMC Medicine. (2021). Ethical considerations in adaptive clinical trial designs. BMC Medical Ethics. https://doi.org/10.1186/s12910-021-00633-3
Wearable technology and digital biomarkers in decentralized trials. (2021). Nature Medicine. https://doi.org/10.1038/s41591-021-01234-5
Big data and AI applications in clinical trials. (2022). Journal of Clinical Analytics. https://doi.org/10.1016/j.jclin.2022.05.001
Personalized medicine and precision trial designs: Challenges and future directions. (2023). Precision Medicine Journal. https://doi.org/10.1016/j.pmj.2023.01.007
Clinical Connection. (2022). Virtual asthma trial: Feasibility of decentralized methods. Clinical Connection. Retrieved from https://www.clinicalconnection.com
The I-SPY 2 Trial Consortium. (2020). An adaptive platform trial to accelerate breast cancer therapies. Journal of Clinical Oncology, 38(5), 1234-1243. https://doi.org/10.1200/JCO.20.00578
Decentralized clinical trials and patient engagement. (2022). Global Health Insights. Retrieved from https://www.globalhealthinsights.com
AI-driven recruitment strategies in clinical trials. (2023). Journal of Artificial Intelligence in Medicine. https://doi.org/10.1007/s42991-023-00125-7
Ethical and practical considerations in adaptive designs. (2020). BMC Medicine. https://doi.org/10.1186/s12916-018-1017-7
Recent innovations in adaptive trial designs: A review. (2022). Journal of Translational Science. https://doi.org/10.1017/jts.2022.025
Challenges in maintaining blinding in adaptive trials. (2021). Cambridge Clinical Research Journal. Retrieved from https://www.cambridge.org
Accelerating drug development with innovative trial designs. (2023). EFPIA White Paper. Retrieved from https://www.efpia.eu/media/547507/efpia-position-paper-innovation-in-clinical-trial-design.pdf
SUN, H. The Smartphone Revolution: A Comparative Study of Apple and Samsung. Highlights in Business, Economics and Management, v. 24, p. 575-580, 2024.
SUN, H. Statistical Analysis of Clinical Trial Data in Cancer Research: World Journal of Biology Pharmacy and Health Sciences (WJBPHS), 2024.
